CoChat

Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics

Seeman, P, Ko, F, Tallerico, T · 2005 · Molecular Psychiatry

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Although phencyclidine and ketamine are used to model a hypoglutamate theory of schizophrenia, their selectivity for NMDA receptors has been questioned. To determine the affinities of phencyclidine, ketamine, dizocilpine and LSD for the functional high-affinity state of the dopamine D2 receptor, D2High, their dissociation constants (Ki) were obtained on [3H]domperidone binding to human cloned dopamine D2 receptors. Phencyclidine had a high affinity for D2High with a Ki of 2.7 nM, in contrast to its low affinity for the NMDA receptor, with a Ki of 313 nM, as labeled by [3H]dizocilpine on rat striatal tissue. Ketamine also had a high affinity for D2High with a Ki of 55 nM, an affinity higher than its 3100 nM Ki for the NMDA sites. Dizocilpine had a Ki of 0.3 nM at D2High, but a Kd of 1.8 nM at the NMDA receptor. LSD had a Ki of 2 nM at D2High. Because the psychotomimetics had higher potency at D2High than at the NMDA site, the psychotomimetic action of these drugs must have a major contribution from D2 agonism. Because these drugs have a combined action on both dopamine receptors and NMDA receptors, these drugs, when given in vivo, test a combined hyperdopamine and hypoglutamate theory of psychosis.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.mp.4001682

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. Van Rossum JM . The significance of dopamine-receptor blockade for the action of neuroleptic drugs. In: Brill H, Cole J, Deniker P, Hippius H, Bradley PB (eds). Neuropsychopharmacology, Proceedings of the 5th Collegium Internationale Neuropsychopharmacologicum. Excerpta Medica Foundation: Amsterdam, 1967, pp 321–329.

Cited by

See all 200

Metadata

Authors
Seeman, P., Ko, F., & Tallerico, T.
Affiliations
University of Toronto (CA)
Corresponding author
Seeman, P
Venue
Molecular Psychiatry
Published
2005-04-26
Volume
10
Issue
9
Pages
877-883
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2024217117
Cited by
200
References
38
Citations by year
2026: 3 · 2025: 7 · 2024: 8 · 2023: 4 · 2022: 4 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 11 · 2017: 9 · 2016: 5 · 2015: 14 · 2014: 5 · 2013: 9 · 2012: 9
FWCI
8.40
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
dopamine D2 receptor, NMDA receptor, phencyclidine, ketamine, LSD, MK-801, psychotomimetics, schizophrenia, receptor binding affinity, dissociation constant
MeSH terms
Animals, Cloning, Molecular, Corpus Striatum, Domperidone, Dopamine, Cricetinae, Ketamine, Kinetics, Lysergic Acid Diethylamide, Membrane Glycoproteins, Nerve Tissue Proteins, Phencyclidine, Dizocilpine Maleate, CHO Cells, Receptors, Dopamine D2, Excitatory Amino Acid Antagonists, Membrane Transport Proteins, Dopamine Plasma Membrane Transport Proteins, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. https://app.cochat.ai/papers/10.1038/sj.mp.4001682
The paper
Seeman, P., Ko, F., & Tallerico, T. (2005). Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Molecular Psychiatry. https://doi.org/10.1038/sj.mp.4001682

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.